
Results
51
Key industries
51 companies
Travere Therapeutics
Market Cap: US$2.5b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$26.84
7D
-4.2%
1Y
26.1%
Supernus Pharmaceuticals
Market Cap: US$2.8b
A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$47.76
7D
-4.9%
1Y
46.1%
Journey Medical
Market Cap: US$220.5m
Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$6.63
7D
-11.0%
1Y
1.4%
Perrigo
Market Cap: US$1.3b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$9.25
7D
-4.8%
1Y
-66.7%
Arcutis Biotherapeutics
Market Cap: US$2.8b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$22.21
7D
-2.4%
1Y
28.5%
SkyWest
Market Cap: US$3.6b
Through its subsidiaries, engages in the operation of a regional airline in the United States.
SKYW
US$87.89
7D
-3.3%
1Y
-8.1%
Vontier
Market Cap: US$5.0b
Provides mobility ecosystem solutions worldwide.
VNT
US$35.20
7D
-3.0%
1Y
1.9%
Jazz Pharmaceuticals
Market Cap: US$11.1b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$180.62
7D
-0.8%
1Y
27.2%
RXO
Market Cap: US$2.2b
Engages in truck brokerage business in the United States, Canada, Mexico, Asia, and Europe.
RXO
US$13.23
7D
10.6%
1Y
-30.5%
Bio-Rad Laboratories
Market Cap: US$7.2b
Develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.
BIO
US$264.49
7D
1.2%
1Y
3.1%
Amphastar Pharmaceuticals
Market Cap: US$884.7m
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$19.50
7D
0.5%
1Y
-31.5%
Insight Enterprises
Market Cap: US$2.2b
Provides information technology, hardware, software, and services in the United States, rest of North America, Europe, Middle East, Africa, and the Asia-Pacific.
NSIT
US$70.71
7D
-13.1%
1Y
-55.9%
Axalta Coating Systems
Market Cap: US$5.4b
Through its subsidiaries, manufactures, markets, and distributes high-performance coatings systems in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
AXTA
US$25.44
7D
-8.9%
1Y
-26.7%
Exagen
Market Cap: US$66.9m
Designs, develops, and commercializes various testing products under the AVISE brand in the United States.
XGN
US$2.78
7D
-12.0%
1Y
-31.4%
Forward Air
Market Cap: US$488.1m
Operates as an asset-light freight and logistics company in the United States, Mexico, Europe, Asia, and Canada.
FWRD
US$15.47
7D
-3.6%
1Y
-28.7%